ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,012 Cr | ₹1,213 Cr | ₹893 Cr | ₹948 Cr | ₹727 Cr |
What is the latest Cash Flow from Operating Activities ratio of ABBOTT INDIA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,012 Cr |
| Mar2024 | ₹1,213 Cr |
| Mar2023 | ₹893 Cr |
| Mar2022 | ₹948 Cr |
| Mar2021 | ₹727 Cr |
How is Cash Flow from Operating Activities of ABBOTT INDIA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,012 Cr | -16.57 | |
| Mar2024 | ₹1,213 Cr | 35.75 | |
| Mar2023 | ₹893 Cr | -5.73 | |
| Mar2022 | ₹948 Cr | 30.40 | |
| Mar2021 | ₹727 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹59,107.7 Cr | 2.8% | 6.9% | -19.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 2.8% |
6.9% |
-19.6% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses